Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2017-04-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
2016年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report for 2016" from Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It details the independent directors' attendance at board meetings, their independent opinions on various board resolutions, their role in protecting investor rights, and participation in the annual report audit process. The content focuses on the directors' duties, opinions, and oversight activities rather than presenting financial statements or audit results themselves. The document length is about 2461 characters, which is relatively short and more of a report on director activities rather than a full audit or annual report. It does not contain financial data or audit opinions in the form of an audit report but rather the independent directors' statements and opinions on company governance and audit participation. This fits best under Board/Management Information (MANG), as it relates to the independent directors' activities and governance role rather than a full audit report or annual report. Therefore, the classification is MANG with high confidence.
2017-04-28 Chinese
关于对公司控股股东及其他关联方占用资金情况的专项审计说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report issued by a certified public accounting firm (立信会计师事务所) regarding the non-operating funds occupied and other related party fund transactions of 江苏四环生物股份有限公司 for the fiscal year 2016 (January 1, 2016 to December 31, 2016). It includes detailed audit opinions, responsibilities of management and auditors, and a summary table of related party fund transactions. The document is titled as a "专项审计报告" (Special Audit Report) and contains substantive audit findings and financial data related to the audit of related party transactions. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. It is not a full Annual Report (10-K), nor a brief announcement or certification. The length and content confirm it is the audit report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence.
2017-04-28 Chinese
2016年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled as the "2016年度董事会工作报告" (2016 Annual Board of Directors Work Report) of Jiangsu Sihuan Bio Co., Ltd. It details the activities, meetings, and decisions of the company's board of directors during the 2016 fiscal year. It includes information about board meetings, resolutions, committee work, and attendance of independent directors. The document references the 2016 annual report and other financial reports but does not contain the full annual report or detailed financial statements itself. The length is 2788 characters, which is relatively short and consistent with a board work report rather than a full annual report. The document is a report on board activities rather than a presentation, call transcript, or announcement. Therefore, the most appropriate classification is Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board of directors or senior management activities.
2017-04-28 Chinese
2016年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as a 2016 annual financial settlement report (财务决算报告) for 江苏四环生物股份有限公司, containing detailed financial data including revenue, profit, asset composition, cash flow, and cost analysis for the full year 2016. It includes comprehensive financial statements and analysis for the fiscal year, which is characteristic of an Annual Report. The document length is over 6000 characters, indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2016
2017-04-28 Chinese
关于对公司2016年度财务报告非标审计意见的专项说明
Audit Report / Information Classification · 95% confidence The document is a specialized audit report issued by a certified public accounting firm (立信会计师事务所) regarding the 2016 financial statements of 江苏四环生物股份有限公司. It includes references to the audit opinion, emphasis of matter paragraphs, and compliance with Chinese auditing standards. The document is titled as a '专项审计报告' (special audit report) and discusses the non-standard audit opinion and related explanations. It is not the full annual report but a standalone audit report focusing on the audit opinion and related disclosures. The length of the document (9527 characters) supports it being a full report rather than a brief announcement. Therefore, the document fits the category of Audit Report / Information (AR).
2017-04-28 Chinese
关于召开2016年年度股东大会通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2016 Annual General Meeting (AGM) of Jiangsu Sihuan Bioengineering Co., Ltd. It includes details about the meeting date, voting procedures, agenda items such as the 2016 annual report, financial statements, profit distribution plan, appointment of auditors, and remuneration for directors and senior management. The document is primarily an announcement inviting shareholders to attend and vote at the AGM, rather than the actual annual report or financial statements themselves. The document length is 4272 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2017-04-28 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.